CXM holder files Rule 144 notice to sell 41,163 common shares

A holder of CXM common stock has filed a Rule 144 notice to sell 41,163 shares.

Rhea-AI Filing Summary

A holder of CXM common stock has filed a Rule 144 notice to sell 41,163 shares. The planned sale is to be executed through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of 321,182.54 based on the figures provided. The filing notes that 145,436,454 shares of this class were outstanding at the time of the notice.

The shares to be sold were acquired on 12/08/2025 through the exercise of options under a registered plan, with the purchase price paid in cash on the same date. By signing the notice, the seller represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CXM shares are being sold under this Rule 144 notice?

The notice covers the planned sale of 41,163 shares of CXM common stock, as disclosed in the section listing the number of shares or other units to be sold.

What is the aggregate market value of the CXM shares to be sold?

The filing reports an aggregate market value of 321,182.54 for the 41,163 CXM common shares to be sold.

How many CXM common shares were outstanding at the time of this notice?

The document states that 145,436,454 shares of the relevant class of CXM common stock were outstanding when the notice was prepared.

When and how were the CXM shares being sold acquired?

The shares were acquired on 12/08/2025 through the exercise of options under a registered plan, with the acquisition recorded as a common stock transaction.

How was payment made for the CXM shares acquired before this sale?

The filing indicates that the purchase price was paid in cash on 12/08/2025 in connection with the option exercise under the registered plan.

Which broker is handling the planned sale of CXM shares and on which exchange?

The notice lists Morgan Stanley Smith Barney LLC Executive Financial Services as the broker, with the shares to be sold on the NYSE.

What representation does the seller make about CXM’s undisclosed information?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/08/2025 - 04:09 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001333214
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SPRINKLR, INC.
SEC File Number	001-40528
Address of Issuer	441 9th Avenue 12th Floor New York NEW YORK 10001
Phone	(917) 933-7800
Name of Person for Whose Account the Securities are To Be Sold	YVETTE M KANOUFF
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	41163	321182.54	145436454	12/08/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/08/2025	Exercise of options under a registered plan	Issuer			41163	12/08/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	12/08/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Yvette M Kanouff
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)